Original paper
Higher Surgical Morbidity for Ulcerative Colitis Patients in the Era of Biologics
Abstract
Objective: To investigate differences in surgical approach and postoperative outcomes for patients with ulcerative colitis (UC) before and after the introduction of biologic therapy. Background: Biologic use has dramatically increased since Food and Drug Administration approval of infliximab. Studies conflict as to the effect of these agents on surgical outcomes with some demonstrating worse surgical outcomes whereas others have found no...
Paper Details
Title
Higher Surgical Morbidity for Ulcerative Colitis Patients in the Era of Biologics
Published Date
Apr 27, 2017
Journal
Volume
268
Issue
2
Pages
311 - 317